Denver HIV Risk Score
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Very Low Risk-14–19
- Low Risk20–29
- Moderate Risk30–39
- High Risk40–49
The Denver HIV Risk Score calculates predicting probability of undiagnosed HIV infection in patients aged 13 and older using demographic and behavioral risk factors. Key inputs include age group. Scores guide administering empiric broad-spectrum antimicrobial regimens, infectious source control, and isolation protocols. Routine clinical application promotes standardized evidence-based patient management.
Clinical Guidelines & Evidence
Predicts probability of undiagnosed HIV infection in patients aged 13 and older using demographic and behavioral risk factors.
Clinical Indication
The Denver HIV Risk Score is indicated for bedside clinical practice to support Predicts probability of undiagnosed HIV infection in patients aged 13 and older using demographic and behavioral risk factors.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with suspected sepsis, meningitis, pneumonia, COVID-19, opportunistic infections, or fever of unknown origin. Clinical application is indicated across Infectious disease services, septic shock bays, febrile illness clinics, and isolation units.
Limitations & Contraindications
Timely administration of empiric antibiotic therapy in suspected septic shock must never be delayed for score tabulation.
Clinical Pearls & Action Plan
Blood and site-specific microbiological cultures should be secured prior to administering broad-spectrum antimicrobials.
Denver HIV Risk Score = Age Points + Gender Points + Sexual Practice Points + Injection Drug Use Points + Past HIV Testing Points + Race/Ethnicity Points (optional)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| age_group | string | Yes | Patient age group with variable point assignments |
| gender | string | Yes | Patient gender |
| sexual_practices | string | Yes | Sexual behavior risk factors |
| injection_drug_use | string | Yes | History of injection drug use |
| past_hiv_testing | string | Yes | History of previous HIV testing |
| race_ethnicity | string | No | Race/ethnicity (optional parameter for additional risk stratification) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| -14–19 | Very Low Risk | Very low probability of undiagnosed HIV infection |
| 20–29 | Low Risk | Low probability of undiagnosed HIV infection |
| 30–39 | Moderate Risk | Moderate probability of undiagnosed HIV infection |
| 40–49 | High Risk | High probability of undiagnosed HIV infection |
| 50–81 | Very High Risk | Very high probability of undiagnosed HIV infection |
Evidence-Based References (EBM)
- Haukoos JS, Hopkins E, Conroy AA, et al. Derivation and validation of the Denver Human Immunodeficiency Virus (HIV) risk score for targeted HIV screening. Am J Epidemiol. 2012;175(8):838-846. doi: 10.1093/aje/kwr389.DOI: 10.1093/aje/kwr389
- Hsieh YH, Jung JJ, Shahan JB, et al. Validation of an abbreviated version of the Denver HIV risk score for prediction of HIV infection in an urban emergency department. Acad Emerg Med. 2014;21(7):757-767. doi: 10.1111/acem.12413.DOI: 10.1111/acem.12413
- Haukoos JS, Lyons MS, Lindsell CJ, et al. Derivation and validation of the Denver Human Immunodeficiency Virus risk score for targeted HIV screening in emergency departments. Am J Epidemiol. 2012;175(8):838-846. doi: 10.1093/aje/kwr389.DOI: 10.1093/aje/kwr389
- Centers for Disease Control and Prevention. Screening for HIV infection: US Preventive Services Task Force recommendation statement. JAMA. 2019;321(23):2326-2336. doi: 10.1001/jama.2019.6587.DOI: 10.1001/jama.2019.6587